Skip to main content

Table 2 Finalized features screened from the step 3 incorporated in the model construction

From: 18F‑FDG PET/CT based radiomics features improve prediction of prognosis: multiple machine learning algorithms and multimodality applications for multiple myeloma

Feature_names

VIF

HR

P-value

Adverse prognostic cytogenetics status

2.633

2.197

0.00018

RISS_Staging

3.645

2.482

0.00009

Red blood cells

4.372

0.613

0.01988

Albumin

4.173

0.447

0.00009

B2M

3.687

1.426

0.00472

Absolute Neutrophils

2.336

0.597

0.03329

wavelet.LLL_firstorder_10Percentile_PET

2.48

1.796

0.00396

exponential_glcm_InverseVariance_PET

2.766

1.995

0.00068

lbp.2D_firstorder_InterquartileRange_PET

4.352

1.470

0.00569

lbp.3D.k_glcm_MCC_PET

2.307

1.479

0.03082

original_shape_MajorAxisLength_PET

4.638

1.777

0.00408

original_shape_MinorAxisLength_CT

3.794

1.704

0.00233

original_ngtdm_Busyness_CT

3.335

1.378

0.00529

exponential_glszm_SmallAreaLowGrayLevelEmphasis_CT

1.52

0.492

0.00273

wavelet.HLH_gldm_SmallDependenceEmphasis_CT

1.765

0.552

0.01432

  1. Riss Revised-International Staging System based staging, B2M β2-microglobulin, ISS International Staging System, HCT Hematocrit, A/G ratio Albumin/ Globulin (Ratio), GFR Glomerular filtration rate, LDH Lactate dehydrogenase
  2. Adverse prognosis cytogenetics Status: FISH analysis confirmed del(17p), t (4;14), t (14;16), add 1q21